Status:
RECRUITING
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Carcinoma
Breast Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and...
Detailed Description
PRIMARY OBJECTIVES: I. Determine the diagnostic performance of the proposed method in a population of pre-biopsy patients with suspicious breast masses and correlate the proposed method results with ...
Eligibility Criteria
Inclusion
- AIM 1: Patient volunteers, ages \>= 18 with suspicious breast masses scheduled for breast biopsy, or at least two weeks or more after breast biopsy
- AIM 2: Patient volunteers, ages \>= 18 who have biopsy proven breast cancer and are going under neoadjuvant chemotherapy and/or endocrine therapy had their baseline MRI and/or ultrasound
Exclusion
- Patients with breast implants or any condition that does not allow proper use of ultrasound (US)
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 29 2027
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT04799535
Start Date
September 1 2019
End Date
November 29 2027
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905